Tenon Medical
Los Gatos, California, United States · Biotechnology, Healthcare, Health Care
Tenon Medical is a surgical innovation company delivering advanced solutions for chronic sacroiliac joint (SIJ) pain. Uniquely positioned in the field, Tenon offers the Catamaran™ SIJ Fusion System—a patented, minimally invasive procedure that uses a single implant to stabilize the SI joint. Backed by a seasoned team with deep expertise in surgical innovation, Tenon Medical is focused on improving
Key facts
- Headquarters
- Los Gatos, California, United States
- Employees
- 28
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (TNON)
- Website
- www.tenonmed.com
- Company page
Recent activity at Tenon Medical
- : SEC 8-K (8.01): Tenon Medical, Inc. announced that it fully repaid its original issue discount senior convertible promissory notes, which had an aggregate principal balance of approximately $5.16 million, ahead of their maturity date of September 11, 2026. This repayment was made on September 9, 2026, and indicates the Company's strong cash position and commitment to managing its debt effectively. The move may have positive strategic implications for Tenon Medical, as it could enhance their financial flexibility moving forward.
- : Tenon Medical secures $3M in a Private Placement offering led by WallachBeth Capital. This funding will help advance their medical innovations.
- : SEC 8-K (1.01): On August 27, 2026, Tenon Medical, Inc. entered into a securities purchase agreement with an institutional investor for a private placement involving the issuance of pre-funded warrants to purchase up to 597,610 shares of its common stock at a price of $5.019 per warrant, along with Series A warrants to purchase up to 1,058,517 shares of common stock. This agreement represents a significant capital raising effort for Tenon Medical, aimed at enhancing operational liquidity. The strategic implications of this private placement are substantial, allowing the company to fund further growth initiatives while providing the investor with a potentially lucrative opportunity to acquire equity at a favorable price.
- : TENON MEDICAL, INC. Secures Funding through Private Placement
- : SEC 8-K (8.01): On August 24, 2026, Tenon Medical, Inc. announced that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) following a notification from the Listing Qualifications staff of The Nasdaq Stock Market LLC. This confirms that the matter regarding compliance is now closed. The notification received and the subsequent press release indicate important regulatory compliance for the company, ensuring its continued listing on Nasdaq, which is strategic for maintaining investor confidence and market presence.
- : TENON MEDICAL
- : TENON MEDICAL
- : Tenon Medical Inc. announced a $2.85 million private funding deal to enhance its treatments for sacro-pelvic disorders, despite a 2.5% drop in stock value.
- : SEC 8-K (5.02): On October 13, 2025, Tenon Medical, Inc. issued a total of 866,642 restricted stock units (RSUs) to its directors and officers as part of the Tenon Medical, Inc. 2022 Equity Incentive Plan. These RSUs are set to vest and convert into common stock of the company in two separate installments: the first 50% will vest on January 1, 2026, and the remaining 50% will vest on July 31, 2026. This issuance is in accordance with an exemption from registration under the Securities Act, signifying substantial equity for the company's management team and aligning their interests with those of the shareholders.
- : Tenon Medical
Tenon Medical funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2026 | Seed | $3.0M |
| Aug 2026 | Series A | $4.3M |
| Mar 2026 | Seed | $4.3M |
| Mar 2026 | Seed | $4.3M |
| Nov 2025 | Funding Round | $2.9M |
Leadership
- Steven Foster, President and Chief Executive Officer
- Jim Palmer, Medical Education Manager
- Rob Harrison, Area Sales Manager, West
- Ivan Howard, Director
- Richard Ferrari, Director
- Steve Van Dick, Executive Officer
- Richard Ginn, Executive Officer
- Steven Foster, Executive Officer
- Jeff Saterdalen, Area Sales Manager
- Kevin Williamson, Chief Financial Officer
- Wyatt Geist, Chief Innovation Officer
- Ivan Howard, Director
Verified email and direct lines for Tenon Medical’s decision-makers are on Fundz. See plans
Tenon Medical in the news
- Tenon Medical, Inc. Announces 1:35 Reverse Stock Split - ACCESS Newswire (Aug 06, 2026)
- Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings - Yahoo Finance (May 01, 2026)
- Tenon Medical’s Catamaran(TM) SI Joint Fusion System Receives Institutional Review Board Approval for Two Strategic Post Market Studies - ACCESS Newswire (Sep 26, 2026)
Companies similar to Tenon Medical
- Dror Ortho-Design · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Treace · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- SynerFuse, Inc. · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Monteris Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- RIVANNA · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
About Tenon Medical: questions and answers
What does Tenon Medical do?
Tenon Medical is a surgical innovation company delivering advanced solutions for chronic sacroiliac joint (SIJ) pain. Uniquely positioned in the field, Tenon offers the Catamaran™ SIJ Fusion System—a patented, minimally invasive procedure that uses a single implant to stabilize the SI joint. Backed by a seasoned team with deep expertise in surgical innovation, Tenon Medical is focused on improving
Where is Tenon Medical headquartered?
Tenon Medical is headquartered in Los Gatos, California, United States.
How many employees does Tenon Medical have?
Tenon Medical has about 28 employees.
Has Tenon Medical raised funding?
Yes. Fundz has recorded 5 funding events for Tenon Medical. The most recent, Seed of $3.0M, was in Aug 2026.
Who leads Tenon Medical?
Steven Foster is a President and Chief Executive Officer at Tenon Medical.
What is the latest news on Tenon Medical?
On Sep 09, 2026, SEC 8-K (8.01): Tenon Medical, Inc. announced that it fully repaid its original issue discount senior convertible promissory notes, which had an aggregate principal balance of approximately $5.16 million, ahead of their maturity date of September 11, 2026. This repayment was made on September 9, 202
Is Tenon Medical a public company?
Yes. Tenon Medical is publicly traded under the ticker TNON.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy